The Type 1 Diabetes market report from DelveInsight provides an in-depth understanding of Type 1 Diabetes, historical and forecasted epidemiology, and Type 1 Diabetes market trends in the 7MM. The report also examines current Type 1 Diabetes treatment practices/algorithms, market drivers, market constraints, and unmet medical needs in order to identify and evaluate the market's underlying potential.
Some of the Important findings from the Type 1 Diabetes Market Report
-
According to the National Diabetes Statistics Report (2020), the United States has 34.2 million people with diabetes in 2018, accounting for 10.5 percent of the total population.
-
In 2018, 210,000 children and adolescents under the age of 20 in the United States were found to be diabetic, of which 187,000 peoplehad Type 1 Diabetes diagnosis (National Diabetes Statistics Report, 2020).
-
Rosenbauer et al. (2019) study showed that males had a greater Type 1 Diabetes prevalence over females in a group of patients over the age of 18.
-
Key Type 1 Diabetes pipelines therapies include Teplizumab (Provention Bio), TOL-3021 (Tolerion), Ladarixin (Dompe Pharmaceutical), AG019 (ActoBiotics), ORMD-0801 (Oramed) and several others.
-
Several pharmaceutical companies such as Provention Bio, Tolerion, Dompe Pharmaceutical, ActoBiotics, Oramed and others are developing novel products for Type 1 Diabetes treatment.
For further information, request sample @ Type 1 Diabetes Management
The Type 1 Diabetes market report covers current treatment practices, new pharmaceuticals, individual therapy market share, and present and predicted Type 1 Diabetes market size from 2018 to 2030, segmented by seven major markets.
Type 1 Diabetes: Overview
Diabetes is a long-term metabolic disease marked by high or low blood glucose (or blood sugar) levels, which can cause considerable damage to the heart, blood vessels, eyes, kidneys, and nerves. Type 1 Diabetes (TD-1), Type 1 Diabetes (TD2), and Gestational Diabetes are the three kinds of diabetes classified clinically.
Type 1 Diabetes is an autoimmune condition that affects the body's immune system. It is the most prevalent type of diabetes in children, but it can strike anyone at any age. The common Type 1 Diabetes symptoms include excessive thirst, impaired vision, dry mouth, upset stomach and vomiting, bedwetting, frequent urination, unexplained weight loss, exhaustion, difficulty breathing, lack of energy, and persistent hunger.
Type 1 Diabetes Epidemiology Segmentation
-
Type 1 Diabetes Total Prevalent Cases
-
Type 1 Diabetes Total Diagnosed Prevalent Cases
-
Type 1 Diabetes Total Gender-Specific Prevalent Diagnosed Cases
-
Type 1 Diabetes Total Age-Specific Prevalent Diagnosed Cases
-
Type 1 Diabetes Treated Cases
Type 1 Diabetes Treatment Landscape
People with Type 1 Diabetes must follow a different plan. A treatment plan, also known as a diabetes management plan, assists people in managing their diabetes while remaining healthy and active. Everyone's plan is different, and it is based on a person's health needs as well as the recommendations of the diabetes health care team. The treatment's goal is to keep your blood sugar levels as close to normal as possible in order to delay or prevent complications.
Forxiga (dapagliflozin) and sotagliflozin (sold as Zynquista) are EMA approved Type 1 Diabetes drugs used for treating the patients with Type 1 Diabetes.
Type 1 Diabetes Market
Owing to the rising prevalence and the projected launch of new therapies such as Teplizumab (Provention Bio), TOL-3021 (Tolerion), Ladarixin (Dompe Pharmaceutical), AG019 (ActoBiotics), ORMD-0801 (Oramed) and others, the Type 1 Diabetes market is predicted to rise during the forecast period, 2021–2030.
Get an overview about diabetes @ Type 1 Diabetes Market Size
Type 1 Diabetes Pipeline Therapies and Key Players
-
Teplizumab: Provention Bio
-
TOL-3021: Tolerion
-
Ladarixin: Dompe Pharmaceutical
-
AG019: ActoBiotics
-
ORMD-0801: Oramed
Type 1 Diabetes Market Drivers
-
Rise in Insulin consumption as the number of diabetic patients increases
-
Increase in R&D
-
Uptake of novel ultra-rapid-acting and ultra-long-acting insulin analogs
Type 1 Diabetes Market Barriers
-
Entry of Biosimilars
-
High treatment and diagnosis Cost
-
Inadequate reimbursement policies
Scope for the Report
Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain and France) and Japan)
Study Period: 2018-30
Type 1 Diabetes Key Companies: Provention Bio, Tolerion, Dompe Pharmaceutical, ActoBiotics, Oramed, among others.
Type 1 Diabetes Key Pipeline Therapies: Teplizumab (Provention Bio), TOL-3021 (Tolerion), Ladarixin (Dompe Pharmaceutical), AG019 (ActoBiotics), ORMD-0801 (Oramed), and others.
Type 1 Diabetes Segmentation: By Geography, By Type 1 Diabetes drugs
Analysis: Comparative and conjoint analysis of Type 1 Diabetes emerging therapies
Tools Used: SWOT Analysis
Case Studies
KOL’s Views
Analyst’s Views
Table of Contents
| 1. | Report Introduction |
| 2. | Executive Summary of Type 1 Diabetes |
| 3. | SWOT Analysis of Type 1 Diabetes |
| 4. | Type 1 Diabetes: Patient Share (%) Overview at a Glance |
| 5. | Type 1 Diabetes: Market Overview (%) at a Glance |
| 6. | Type 1 Diabetes Disease Background and Overview |
| 7. | Type 1 Diabetes Epidemiology and Patient Population |
| 8. | Country-Specific Patient Population of Type 1 Diabetes |
| 9. | Type 1 Diabetes Current Treatment and Medical Practices |
| 10 | Type 1 Diabetes Patient Journey |
| .11. | Type 1 Diabetes Unmet Needs |
| 12. | Type 1 Diabetes Key Endpoint of Clinical Trials |
| 13. | Type 1 Diabetes Marketed Products |
| 14. | Type 1 Diabetes Emerging Therapies |
| 15. | Conjoint Analysis of Type 1 Diabetes Therapies |
| 16. | Type 1 Diabetes: Market Size of 7MM |
| 17. | Type 1 Diabetes Country-Wise Market Analysis (2018 –2030) |
| 18. | Type 1 Diabetes Market Access and Reimbursement |
| 19. | Type 1 Diabetes Market drivers |
| 20. | Type 1 Diabetes Market barriers |
| 21. | Appendix |
| 22. | DelveInsight Capabilities |
| 23. | Disclaimer |
| 24. | About DelveInsight |
For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare and Biotech Blog Posts
Related Reports
Get comprehensive historical and forecast analysis of Dementia with Diabetes Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as vTv Therapeutics, Novo Nordisk, among others.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email:Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/
